Literature DB >> 18008348

Fine-needle aspiration in the diagnosis of head and neck lesions: a review and discussion of problems in differential diagnosis.

Lester J Layfield1.   

Abstract

Fine-needle aspiration (FNA) has become the predominant initial diagnostic technique for lesions at a number of sites within the head and neck. The technique has achieved this level of usage because it is relatively inexpensive, rapid to perform, well accepted by patients, associated with low morbidity, and has a relatively high diagnostic accuracy. Sites in the head and neck amenable to FNA include the thyroid, cervical masses and nodules, salivary glands, intraoral lesions and lesions in the paraspinal area and base of skull. Diagnostic accuracy is dependent on the site of aspiration as well as the skill of the individual performing and interpreting the FNA. Studies have shown that FNA is most accurate when the individual interpreting the FNA is the same individual who obtained the aspirate material. Each site undergoing FNA within the head and neck is associated with a set of differential diagnoses and diagnostic challenges which will be discussed. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 18008348     DOI: 10.1002/dc.20769

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  17 in total

1.  Different histological subtypes of parotid gland tumors: CT findings and diagnostic strategy.

Authors:  Zhi-Feng Xu; Fang Yong; Tian Yu; Ying-Yu Chen; Qiang Gao; Tao Zhou; Ai-Zhen Pan; Ren-Hua Wu
Journal:  World J Radiol       Date:  2013-08-28

2.  How trustworthy is a diagnosis in head and neck surgical pathology? A consideration of diagnostic discrepancies (errors).

Authors:  Julia A Woolgar; Alfio Ferlito; Kenneth O Devaney; Alessandra Rinaldo; Leon Barnes
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-22       Impact factor: 2.503

Review 3.  A systematic review of ultrasound-guided FNA of lesions in the head and neck--focusing on operator, sample inadequacy and presence of on-spot cytology service.

Authors:  A Ganguly; G Burnside; P Nixon
Journal:  Br J Radiol       Date:  2014-09-23       Impact factor: 3.039

Review 4.  Scalp junctional nevus with malignant transformation (melanoma) metastatic to parotid lymph node region, cervical lymph nodes and the back: a case report and review of literature.

Authors:  Zhuo-Ping Liang; Sheng-En Xu; Liang Jiang; Chong Zhao; Xiao-Qiang Sun; Gang Qin
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Management of lymph node metastases from an unknown primary site to the head and neck (Review).

Authors:  Shi Min Zhuang; Xi-Fu Wu; Jing-Jia Li; Ge-Hua Zhang
Journal:  Mol Clin Oncol       Date:  2014-07-29

6.  Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO).

Authors:  Jens Müller von der Grün; Dimitra Bon; Claus Rödel; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2018-05-14       Impact factor: 3.621

7.  Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer.

Authors:  R O Phillips; F S Sarfo; F Osei-Sarpong; A Boateng; I Tetteh; A Lartey; E Adentwe; W Opare; K B Asiedu; M Wansbrough-Jones
Journal:  J Clin Microbiol       Date:  2009-02-09       Impact factor: 5.948

8.  The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC).

Authors:  Tong Sun; Ali Akalin; Karen Dresser; Andrew H Fischer; Tao Zuo
Journal:  Head Neck Pathol       Date:  2020-07-13

9.  The benefits of on-site cytology with ultrasound-guided fine needle aspiration in a one-stop neck lump clinic.

Authors:  A Ganguly; T E Giles; P A Smith; F E White; P P Nixon
Journal:  Ann R Coll Surg Engl       Date:  2010-07-26       Impact factor: 1.951

10.  Ultrasound-guided fine-needle aspiration for retrojugular lymph nodes in the neck.

Authors:  Dong Wook Kim
Journal:  World J Surg Oncol       Date:  2013-05-30       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.